Clinical Trials Logo

Clinical Trial Summary

In this study, 300 patients who underwent painless abortion in Ruijin Hospital and sub-central hospitals were selected through a multi-center randomized controlled study, and 300 patients who underwent painless abortion in Ruijin Hospital and each sub-center hospital were divided into intravenous anesthesia with propofol with fentanyl (group F) and propofol with oxycodone (group O) by stratified group randomization method 1:1. The difference between the postoperative anxiety scores and depression scores of the two groups was observed, and the postoperative anxiety, depression and numerical pain scores were recorded. Finally, the relevant data were statistically analyzed and conclusions were drawn.


Clinical Trial Description

This study is a multicenter, randomized controlled clinical study. A total of 300 patients who underwent elective painless abortion surgery in Ruijin Hospital and other sub-central hospitals were enrolled, and they were randomly divided into 1:1 patients who received intravenous anesthesia with propofol with fentanyl (group F) and propofol with oxycodone (group O). The scores of anxiety, depression and postoperative numerical rating scale (NRS) before and after surgery were observed, and the levels of serum stress response factors and inflammatory cytokines were monitored. The effects of oxycodone on anxiety, depression and postoperative acute pain in patients with painless abortion were investigated. 1. Main observation indicators: The difference between the post-operative anxiety score and the preoperative anxiety score 2. Secondary Observational Indicators: - Post-operative anxiety score - The difference between the post-operative depression score and the preoperative depression score - Post-operative depression score - Pain assessment after surgical recovery (NRS) - Laboratory tests - Patient and family satisfaction with postoperative analgesic treatment ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06435949
Study type Interventional
Source Ruijin Hospital
Contact
Status Not yet recruiting
Phase Early Phase 1
Start date July 1, 2024
Completion date June 30, 2026

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04331847 - Abortion-related Morbidity and Mortality in Conflict-affected and Fragile Settings Study